GSK8573

CAS No. 1693766-04-9

GSK8573 ( —— )

Catalog No. M22027 CAS No. 1693766-04-9

GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 In Stock
5MG 80 In Stock
10MG 132 In Stock
25MG 248 In Stock
50MG 370 In Stock
100MG 537 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK8573
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).
  • Description
    GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    BRD9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1693766-04-9
  • Formula Weight
    323.39
  • Molecular Formula
    C20H21NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:22 mg/mL (68.03 mM; Need ultrasonic)
  • SMILES
    CCCOC1=CC2=C(C=C(N2C=C1)C(C)=O)C1=CC(OC)=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chen P, et al. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B. J Med Chem. 2016 Feb 25;59(4):1410-24.
molnova catalog
related products
  • OXFBD04

    OXFBD04 is a potent and selective inhibitor of BRD4(IC50 of 166 nM).

  • OTX015

    OTX015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4. Phase 1.

  • GSK8573

    GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).